APA (7th ed.) Citation

DH, H., RA, D., AL, R., A, H., RJ, L., NK, W., . . . AM, B. (2026). Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2. Journal of medicinal chemistry, 69(4), 4187. https://doi.org/10.1021/acs.jmedchem.5c02796

Chicago Style (17th ed.) Citation

DH, Haymer, et al. "Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2." Journal of Medicinal Chemistry 69, no. 4 (2026): 4187. https://doi.org/10.1021/acs.jmedchem.5c02796.

MLA (9th ed.) Citation

DH, Haymer, et al. "Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2." Journal of Medicinal Chemistry, vol. 69, no. 4, 2026, p. 4187, https://doi.org/10.1021/acs.jmedchem.5c02796.